ClinicalTrials.govpublic full text
Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment.
brms1, performance status zero to two for beginning the study, patient with a maximum of one chemotherapy, patient with progression after taxanes, receptor her two positive, lapatinib, metastatic breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 916341
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.